AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)
|
35.09 -0.27 (-0.76%) Mar 16 - Close |
|
|
|
After-Hours 35.36 0.00 (0.00%) Mar 16 15:59ET
- Compare AMAG with:
- View: Line | Candlestick
Company Profile
AMAG Pharmaceuticals, Inc.
125 CambridgePark Drive
Cambrigde, MA 02140
United States - Map
Phone: (617) 498-3300
Fax: (617) 499-3361
Website: www.advancedmagnetics.com
State of incorporation: Delaware
CEO: Dr. Brian J.G. Pereira, M.D.
Employees: 283
Sector: Healthcare
Industry Group: Drugs
Industry: Diagnostic Substances
A biopharmaceutical company
A biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease.
Recent news for AMAG
-
Business Wire - 7 hours ago
-
4-Star Stocks Poised to Pop: 3SBio
Motley Fool - Yesterday at 9:43AM (EST)
-
AMAG Anemia Drug Eyes Growing Market
Investor's Business Daily - Mar 05 at 6:22PM (EST)
-
AMAG PHARMACEUTICALS INC. Financials
EDGAR Online Financials - Mar 05 at 1:04PM (EST)
-
AMAG Pharmaceuticals, Inc. to Present at the Cowen and Company 30th Annual Healthcare Conference
Business Wire - Mar 02 at 4:25PM (EST)
-
Zacks.com - Mar 02 at 8:39AM (EST)
-
Passport Capital Hedges With ETFs and Options
Seeking Alpha - Mar 02 at 1:15AM (EST)
-
AMAG Pharmaceuticals, Inc. Earnings Call scheduled for 8:00 am ET today
CCBN - Mar 01 at 8:00AM (EST)
-
Wall Street Breakfast: Must-Know News
Seeking Alpha - Mar 01 at 7:20AM (EST)
-
EDGAR Online - Mar 01 at 7:00AM (EST)